Your email has been successfully added to our mailing list.

×
0 0 0.00126342387871136 0.00126342387871136 -0.00105285323225951 0.00336913034323008 -0.0014739945251632 0.00336913034323008
Stock impact report

AstraZeneca to test impact of cancer drug Calquence on coronavirus patients [Reuters (UK)]

AstraZeneca PLC - American Depositary Shares (AZN) 
Last astrazeneca plc - american depositary shares earnings: 2/5 04:00 pm Check Earnings Report
US:NYSE Investor Relations: astrazeneca.com/investor-relations.html
Company Research Source: Reuters
AstraZeneca to start Calquence in COVID-19 trial - Reuters 2 Min Read (Reuters) - AstraZeneca Plc ( AZN.L ) said on Tuesday that it would start a clinical trial to assess the potential of Calquence in the treatment of the exaggerated immune response associated with COVID-19 infection in severely ill patients. Calquence is a BTK inhibitor and currently used to treat certain types of blood cancers. The drug has already been approved for the treatment of adult patients with chronic lymphocytic leukaemia in the United States and a number of other countries. The announcement from AstraZeneca comes at a time when drugmakers around the world have been forced to pause or slow down clinical trials for other disease areas, as they focus on testing potential treatments for the fast-spreading coronavirus. The goal of the trial is to evaluate the effectiveness and safety of adding the drug to best supportive care to reduce mortality and the need for assisted ventilation in patients with life-thr Show less Read more
Impact Snapshot
Event Time:
AZN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for AZN alerts
Opt-in for
AZN alerts

from News Quantified
Opt-in for
AZN alerts

from News Quantified